Evidence-based articles for people using Mounjaro and tirzepatide
With tirzepatide shortages driving patients toward compounded versions, understanding the real risks and regulatory gaps matters more than ever. Here's what you need to know before you fill that prescription.
Headaches are one of the most frequently reported side effects during Mounjaro treatment. Learn what causes them, when they're normal, and which symptoms demand medical attention.
Wondering how to stop Mounjaro without gaining weight? Research from SURMOUNT trials shows what happens when you discontinue tirzepatide and strategies for managing weight after stopping.
Short-term diets often fail because they ignore the biology behind hunger and satiety. See how clinical weight loss programs with Mounjaro differ from a simple prescription and who benefits most from structured medical oversight.
Wondering how to get more from your Mounjaro treatment through diet and lifestyle? These evidence-based strategies may help support the medication's effects naturally.
The FDA expanded Mounjaro's approval to include cardiovascular risk reduction. Here's what tirzepatide patients and healthcare providers need to know about this landmark decision.
Experiencing hair shedding while on Mounjaro? Learn the science behind telogen effluvium, risk factors, and practical steps to minimize hair loss during your weight loss journey.
Tirzepatide 60mg does not exist as an approved medication. Here's what you need to know about the actual dose range, why 15mg is the ceiling, and what happens with higher amounts.
Discover how the Zepbound Kwikpen works, its dosing strengths, storage requirements, and how it compares to traditional injection methods and Mounjaro.
Many Brazilians are asking about Zepbound and how it compares to Mounjaro. Here's what you need to know about availability, pricing, and your weight loss options.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app
